These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 3293319)

  • 1. [Thrombocyte function and the prostacyclin-thromboxane system in patients with acute myocardial infarct].
    Aliavi AL
    Vrach Delo; 1988 Mar; (3):42-4. PubMed ID: 3293319
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of platelet aggregation, serum thromboxane and prostacyclin in lung cancer and pulmonary metastatic patients following operation].
    Takeda H; Kashimura Y; Takeoka T; Hashimoto M; Tanabe T
    Kyobu Geka; 1984 Sep; 37(10):773-7. PubMed ID: 6389949
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemistry of coronary artery disease--prostaglandins].
    Tada M; Kuzuya T; Ohmori M
    Rinsho Byori; 1983 Aug; 31(8):854-9. PubMed ID: 6361336
    [No Abstract]   [Full Text] [Related]  

  • 5. Altered sensitivity to prostacyclin may be involved in the exercise-induced activation of platelets in patients with ischemic heart disease.
    Kishi Y; Numano F; Oniki T; Yajima M; Numano F
    Prog Clin Biol Res; 1989; 301():181-5. PubMed ID: 2508101
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological correction by roxicam of the prostacyclin-thromboxane system in acute myocardial infarction complicated by heart failure].
    Shushliapin OI; Shelest AN; Khosseĭn Shakhavat AF
    Kardiologiia; 1991 Aug; 31(8):39-41. PubMed ID: 1795470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin and thromboxane levels during cardiac ischemia in dogs.
    Prosdocimi M; Tessari F; Finesso M; Gorio A; Dejana E; Languino LR; Del Maschio A; de Gaetano G
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():93-6. PubMed ID: 3159235
    [No Abstract]   [Full Text] [Related]  

  • 8. [The prostacyclin-thromboxane system and thrombocytic-vascular hemostasis in patients with ischemic heart disease in the preoperative period].
    Abbakumov VV; Vinnitskiĭ LI; Kattakhanova RIu; Studennikova LN; Egorova IA; Smirnova LA
    Anesteziol Reanimatol; 1992; (1):42-4. PubMed ID: 1524251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of thromboxane B2 by platelets and concentrations of thromboxane B2 and 6-keto-prostaglandin F1 alpha in plasma after acute ethanol ingestion.
    Kangasaho M; Hillbom M; Kaste M; Wuorela H; Vapaatalo H
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():223-8. PubMed ID: 6303086
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo formation of prostacyclin and thromboxane A2 at the site of platelet-vascular interaction in humans.
    Nowak J; FitzGerald GA
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():208-11. PubMed ID: 2959050
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma thromboxane B2 and capacity of the aorta to produce prostacyclin in arteriopathies of the lower extremities].
    Jouve R; Rolland PH; Pellegrin E; Mercier C; Delboy C; Serradimigni A
    J Mal Vasc; 1983; 8(3):221-5. PubMed ID: 6355348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma TXB2, 6-keto-PGF1 alpha content and their ratio in myocardial infarction patients].
    Bai XJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Dec; 17(6):361-2. PubMed ID: 2637134
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucocorticoids do not decrease thromboxane and prostacyclin levels in human blood.
    Puustinen T; Dahl ML; Uotila P; Haataja M
    Prostaglandins Leukot Med; 1984 Sep; 15(3):409-10. PubMed ID: 6387721
    [No Abstract]   [Full Text] [Related]  

  • 14. Thromboxane, prostacyclin, beta-thromboglobin, and diabetes mellitus.
    Brunner D; Klinger J; Weisbort J; Tuval M; Nakash J; Rosenberg CH; Nissim S
    Clin Ther; 1984; 6(5):636-42. PubMed ID: 6206948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane formation by platelets and platelet sensitivity to prostacyclin in patients with acute myocardial infarction.
    Strano A; Davi G; Traina M; Novo S; Raineri A
    Thromb Haemost; 1981 Dec; 46(4):759. PubMed ID: 7036402
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
    Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma prostacyclin and thromboxane concentration in healthy children and in offspring of parents suffering from myocardial infarct].
    Mihai K; Petö J; Kolthay E; Makáry A; Timár S; Lusztig G
    Orv Hetil; 1991 Jul; 132(30):1627-9. PubMed ID: 1866156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostacyclin and thromboxane in diabetic children.
    Kaar ML; Kaapa P; Viinikka L; Ylikorkala O
    Prostaglandins Leukot Med; 1983 Jul; 11(3):339-44. PubMed ID: 6351104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of the complex treatment of stable stenocardia on the status of the prostacyclin-thromboxane system].
    Khimenko PL
    Ter Arkh; 1986; 58(5):95-8. PubMed ID: 2874621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
    Zahavi J; Zahavi M
    Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.